0001493152-23-029445.txt : 20230818 0001493152-23-029445.hdr.sgml : 20230818 20230818162149 ACCESSION NUMBER: 0001493152-23-029445 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230817 FILED AS OF DATE: 20230818 DATE AS OF CHANGE: 20230818 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Rivard Paul CENTRAL INDEX KEY: 0001857479 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36268 FILM NUMBER: 231186121 MAIL ADDRESS: STREET 1: C/O AKERS BIOSCIENCES, INC. STREET 2: 1185 AVENUE OF THE AMERICAS, 3RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MyMD Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001321834 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 000000000 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 855 N. WOLFE STREET STREET 2: SUITE 623 CITY: BALTIMORE STATE: MD ZIP: 21205 BUSINESS PHONE: 856-848-8698 MAIL ADDRESS: STREET 1: 855 N. WOLFE STREET STREET 2: SUITE 623 CITY: BALTIMORE STATE: MD ZIP: 21205 FORMER COMPANY: FORMER CONFORMED NAME: Akers Biosciences, Inc. DATE OF NAME CHANGE: 20170413 FORMER COMPANY: FORMER CONFORMED NAME: Akers Biosciences Inc DATE OF NAME CHANGE: 20050325 4 1 ownership.xml X0508 4 2023-08-17 0 0001321834 MyMD Pharmaceuticals, Inc. MYMD 0001857479 Rivard Paul 855 N. WOLFE STREET, SUITE 601 BALTIMORE MD 21205 0 1 0 0 Chief Legal Officer 0 Common stock 2023-08-17 4 P 0 25000 1.1232 A 250000 D /s/ Paul Rivard 2023-08-18